Molecularly Guided Drug Repurposing for Cholangiocarcinoma: An Integrative Bioinformatic Approach

Background: Cholangiocarcinoma (CCA) has a complex immune microenvironment architecture, thus possessing challenges in its characterization and treatment. This study aimed to repurpose FDA-approved drugs for cholangiocarcinoma by transcriptomic-driven bioinformatic approach. Methods: Cox-proportiona...

Descripción completa

Detalles Bibliográficos
Autores principales: Venkatraman, Simran, Balasubramanian, Brinda, Pongchaikul, Pisut, Tohtong, Rutaiwan, Chutipongtanate, Somchai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871819/
https://www.ncbi.nlm.nih.gov/pubmed/35205315
http://dx.doi.org/10.3390/genes13020271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871819/
https://www.ncbi.nlm.nih.gov/pubmed/35205315
http://dx.doi.org/10.3390/genes13020271

Ejemplares similares